# Imbria Pharmaceuticals, Inc. — Form D/A

Imbria Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2025-12-16. The offering totals $144.2M, of which $66.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-12-16
- Form: D/A
- Accession: 0001104659-25-121539
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $144.2M
- Amount sold: $66.7M
- Remaining: $77.5M
- Investors: 10
- Date of first sale: 2025-03-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-542691

## Issuer

- Name: Imbria Pharmaceuticals, Inc.
- CIK: 0001745672
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 265 FRANKLIN STREET, BOSTON, MA, 02110
- Phone: 917-657-5069

## Officers, directors & promoters (16)

| Name | Role | Location |
| --- | --- | --- |
| Zina Affas Besse | Director | WOODLAND HILLS, CA |
| Pavan Cheruvu | Director | Boston, MA |
| Charles Dunn | Director | Boston, MA |
| Ken Horne | Director | Boston, MA |
| Andrew Levin | Director | BOSTON, MA |
| Luse Rebecca | Director | Boston, MA |
| Alvin Shih | Director | Boston, MA |
| Komal Joshi | Executive Officer | Boston, MA |
| Alvin Shih | Executive Officer | Boston, MA |
| Rebecca Luse | Director | Boston, MA |
| James Januzzi | Director | Boston, MA |
| Andrew C Levin | Director | Boston, MA |
| David-Alexandre C Gros | Director | Boston, MA |
| David-Alexandre C Gros | Executive Officer | Boston, MA |
| James C Januzzi | Director | Boston, MA |
| Pieter C Boelhouwer | Director | Rancho Santa Fe, CA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-04-01](https://search.stillhousedata.com/formd/0001745672-25-000003) | D | $124.2M | $59.2M |
| [2020-07-02](https://search.stillhousedata.com/formd/0001713695-20-000004) | D | $80.7M | $40.7M |
| [2018-07-09](https://search.stillhousedata.com/formd/0001745672-18-000001) | D | $40.2M | $40.2M |

## More

- [CIK 1745672 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1745672&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001104659-25-121539.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.